4dmedical Limited Stock Performance
| FDMDF Stock | USD 2.35 0.50 27.03% |
4DMedical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning 4DMedical are expected to decrease at a much lower rate. During the bear market, 4DMedical is likely to outperform the market. Use 4DMedical downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness , to analyze future returns on 4DMedical.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in 4DMedical Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, 4DMedical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 80.9 M | |
| Total Cashflows From Investing Activities | -3.5 M |
4DMedical |
4DMedical Relative Risk vs. Return Landscape
If you would invest 130.00 in 4DMedical Limited on September 27, 2025 and sell it today you would earn a total of 105.00 from holding 4DMedical Limited or generate 80.77% return on investment over 90 days. 4DMedical Limited is currently producing 1.5622% returns and takes up 13.0197% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than 4DMedical, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
4DMedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for 4DMedical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as 4DMedical Limited, and traders can use it to determine the average amount a 4DMedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.12
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | FDMDF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average 4DMedical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of 4DMedical by adding it to a well-diversified portfolio.
4DMedical Fundamentals Growth
4DMedical Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of 4DMedical, and 4DMedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 4DMedical Pink Sheet performance.
| Return On Equity | -0.34 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (34.86) % | |||
| Current Valuation | 55.4 M | |||
| Shares Outstanding | 294.49 M | |||
| Price To Book | 2.69 X | |||
| Price To Sales | 102.71 X | |||
| Revenue | 1.05 M | |||
| EBITDA | (35.25 M) | |||
| Cash And Equivalents | 60.19 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 1.3 M | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (25.27 M) | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 74.31 M | |||
About 4DMedical Performance
By analyzing 4DMedical's fundamental ratios, stakeholders can gain valuable insights into 4DMedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if 4DMedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if 4DMedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
4DMedical Limited operates as a medical technology company in Australia and the United States. The company was incorporated in 2012 and is based in Carlton, Australia. 4Dmedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 95 people.Things to note about 4DMedical Limited performance evaluation
Checking the ongoing alerts about 4DMedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for 4DMedical Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| 4DMedical Limited is way too risky over 90 days horizon | |
| 4DMedical Limited appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.05 M. Net Loss for the year was (24.59 M) with profit before overhead, payroll, taxes, and interest of 280.62 K. | |
| 4DMedical Limited has accumulated about 60.19 M in cash with (25.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 35.0% of the company shares are held by company insiders |
- Analyzing 4DMedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether 4DMedical's stock is overvalued or undervalued compared to its peers.
- Examining 4DMedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating 4DMedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of 4DMedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of 4DMedical's pink sheet. These opinions can provide insight into 4DMedical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 4DMedical Pink Sheet analysis
When running 4DMedical's price analysis, check to measure 4DMedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4DMedical is operating at the current time. Most of 4DMedical's value examination focuses on studying past and present price action to predict the probability of 4DMedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4DMedical's price. Additionally, you may evaluate how the addition of 4DMedical to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |